Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim J.H. | - |
dc.contributor.author | Kim J.S. | - |
dc.contributor.author | Lee J.J. | - |
dc.contributor.author | Kim J.H. | - |
dc.contributor.author | Kim S.Y. | - |
dc.contributor.author | Jung Y.K. | - |
dc.contributor.author | Kwon O.S. | - |
dc.contributor.author | Kim Y.S. | - |
dc.contributor.author | Choi D.J. | - |
dc.contributor.author | Kim J.H. | - |
dc.date.available | 2020-11-02T19:43:18Z | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.issn | 2005-6648 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9879 | - |
dc.description.abstract | Background/Aims: The Ministry of Health and Welfare and the Korea Centers for Disease Control and Prevention in South Korea have been organizing hepatitis B virus (HBV) vertical infection prevention projects since July 2002. In this single-institute study, the results of surveys conducted in target mothers who delivered babies in a tertiary hospital were investigated and analyzed. Methods: Of the 9,281 mothers and their 9,824 neonates born between July 2002 and December 2012, 308 hepatitis B surface antigen (HBsAg)-positive mothers and their 319 neonates were selected for this study, and their records were analyzed retrospectively. Results: A total of 308 mothers were HBsAg-positive, with an HBV prevalence of 3.32% (308/9,281). There were 319 neonates born to these HBsAg-positive mothers, and 252 were confirmed to as either HBsAg-positive or -negative. Four were confirmed as HBsAg-positive, with a 1.59% (4/252) HBV vertical infection rate. All the mothers of neonates who had an HBV vertical infection were hepatitis B e antigen (HBeAg)-positive. Among the HBsAg-positive neonates, three were HBeAg-positive and had an HBV DNA titer of 1.0 × 108 copies/mL. Conclusions: The HBV prevalence of mothers was 3.32% (308/9,281), and their vertical infection rate was 1.59% (4/252). Thus, the South Korean HBV vertical infection prevention projects are effective, and, accordingly, HBV prevalence in South Korea is expected to decrease continuously. © 2014 The Korean Association of Internal Medicine. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Association of Internal Medicine | - |
dc.title | Survey of perinatal hepatitis B virus transmission after Korean National Prevention Program in a tertiary hospital | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3904/kjim.2014.29.3.307 | - |
dc.identifier.scopusid | 2-s2.0-84901351665 | - |
dc.identifier.bibliographicCitation | Korean Journal of Internal Medicine, v.29, no.3, pp 307 - 314 | - |
dc.citation.title | Korean Journal of Internal Medicine | - |
dc.citation.volume | 29 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 307 | - |
dc.citation.endPage | 314 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antivirus agent | - |
dc.subject.keywordPlus | hepatitis B surface antigen | - |
dc.subject.keywordPlus | hepatitis B vaccine | - |
dc.subject.keywordPlus | hepatitis B(e) antigen | - |
dc.subject.keywordPlus | biological marker | - |
dc.subject.keywordPlus | hepatitis B surface antigen | - |
dc.subject.keywordPlus | hepatitis B(e) antigen | - |
dc.subject.keywordPlus | virus DNA | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | clinical effectiveness | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | health program | - |
dc.subject.keywordPlus | health survey | - |
dc.subject.keywordPlus | hepatitis B | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | immunoprophylaxis | - |
dc.subject.keywordPlus | infection prevention | - |
dc.subject.keywordPlus | infection rate | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | newborn | - |
dc.subject.keywordPlus | newborn infection | - |
dc.subject.keywordPlus | nonhuman | - |
dc.subject.keywordPlus | perinatal infection | - |
dc.subject.keywordPlus | pregnancy outcome | - |
dc.subject.keywordPlus | prevalence | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | tertiary care center | - |
dc.subject.keywordPlus | vertical transmission | - |
dc.subject.keywordPlus | virus transmission | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | blood | - |
dc.subject.keywordPlus | genetics | - |
dc.subject.keywordPlus | hepatitis B | - |
dc.subject.keywordPlus | Hepatitis B virus | - |
dc.subject.keywordPlus | immunology | - |
dc.subject.keywordPlus | pregnancy | - |
dc.subject.keywordPlus | prevention and control | - |
dc.subject.keywordPlus | public health | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | tertiary care center | - |
dc.subject.keywordPlus | transmission | - |
dc.subject.keywordPlus | virology | - |
dc.subject.keywordPlus | virus load | - |
dc.subject.keywordPlus | Adult | - |
dc.subject.keywordPlus | Biological Markers | - |
dc.subject.keywordPlus | DNA, Viral | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Health Surveys | - |
dc.subject.keywordPlus | Hepatitis B | - |
dc.subject.keywordPlus | Hepatitis B e Antigens | - |
dc.subject.keywordPlus | Hepatitis B Surface Antigens | - |
dc.subject.keywordPlus | Hepatitis B virus | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Infant, Newborn | - |
dc.subject.keywordPlus | Infectious Disease Transmission, Vertical | - |
dc.subject.keywordPlus | National Health Programs | - |
dc.subject.keywordPlus | Pregnancy | - |
dc.subject.keywordPlus | Prevalence | - |
dc.subject.keywordPlus | Republic of Korea | - |
dc.subject.keywordPlus | Retrospective Studies | - |
dc.subject.keywordPlus | Tertiary Care Centers | - |
dc.subject.keywordPlus | Viral Load | - |
dc.subject.keywordAuthor | Hepatitis B | - |
dc.subject.keywordAuthor | Korea | - |
dc.subject.keywordAuthor | Vaccination | - |
dc.subject.keywordAuthor | Vertical infection transmission | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.